Abstract
Cell-free protein synthesis (CFPS) systems are a powerful platform with immense potential in fundamental research, biotechnology, and synthetic biology. Conventional prokaryotic CFPS systems, particularly those derived from Escherichia coli (E. coli), often rely on complex reaction buffers containing up to thirty-five components, limiting their widespread adoption and systematic optimization. Here, we present an optimized E. coli cell-free protein synthesis (eCFPS) system, which is significantly streamlined for high efficiency. Through systematic screening, we successfully reduced the essential core reaction components from 35 to a core set of 7. The thorough optimization of these seven key components ensured that protein expression levels were not only maintained but even substantially improved. Furthermore, we developed a much simpler procedure for preparing the bacterial cytosolic extracts, a “fast lysate” protocol that eliminates the traditional time-consuming runoff and dialysis steps, thereby enhancing the overall accessibility and robustness of eCFPS. This optimized and user-friendly eCFPS efficiently synthesizes challenging proteins, including functional, self-assembling vimentin, and active restriction endonuclease BsaI despite its strong cytotoxicity, and serves as a powerful tool that will facilitate diverse applications in basic life science research and beyond.
Introduction
Cell-free protein synthesis (CFPS) offers a powerful and flexible platform for biological research and biotechnological applications by reproducing the cellular protein synthesis process in an in vitro environment1,2. Compared to traditional cell-based expression systems, CFPS possesses several notable advantages, including rapid reaction kinetics, ease of operation, independence from cell culture, high tolerance to toxic proteins, and facile incorporation of non-canonical amino acids3–5. These characteristics position CFPS for broad applications in protein engineering, high-throughput screening, synthetic biology, and diagnostic reagent development6,7.
Prokaryotic CFPS systems, especially those based on E. coli lysates, have garnered significant attention for their high protein synthesis yields and compatibility with genetic manipulations8–13. They have played a pivotal role in early molecular biology research and continue to be relevant in industrial protein production and biosensor development1,14–16. However, for a long time, most prokaryotic CFPS protocols have relied on complex buffer systems containing a large number of auxiliary components17,18. A comprehensive analysis of existing literature reveals that the composition of reaction buffers differs widely between protocols, both in the number of optional components and in the concentrations of individual components (Table S1). These complex systems, while effective, often lead to high costs, laborious preparation procedures, and potential interactions among components, posing significant challenges for further optimization and standardization, thereby limiting their widespread adoption in resource-constrained laboratories.
In recent years, the field of eukaryotic CFPS has seen remarkable progress in system optimization and simplification19,20. Highly optimized human in vitro translation systems have demonstrated that high-efficiency protein synthesis can be achieved with a minimal number of core components19. Recognizing the potential of such systematic optimization approaches, we hypothesized that similar strategies could be equally applicable and beneficial for E. coli CFPS systems by thoroughly analyzing the functions of existing components and integrating insights from previous reports on prokaryotic protein synthesis mechanisms. This study aimed to develop a highly simplified yet efficient E. coli cell-free protein synthesis system (eCFPS). We conducted a systematic component reduction screening of traditional eCFPS systems, successfully streamlining the core components from thirty-five to just seven. The subsequent meticulous optimization of these seven key components not only maintained but even improved protein expression levels. Through these dual efforts—simplifying the reaction mixture and developing a high-quality, dialysis-free “fast lysate” preparation—we established a highly accessible and robust eCFPS platform which will accelerate diverse applications in life science research.
Results
Streamlining eCFPS: removal of dispensable components
To develop a more streamlined and efficient eCFPS system, we performed a systematic screening of auxiliary components commonly found in traditional prokaryotic CFPS protocols17,21. Our objective was to identify dispensable components while maintaining or enhancing protein synthesis efficiency, thereby simplifying system preparation and reducing costs. Starting with a comprehensive reaction mixture containing up to thirty-five components17, we iteratively evaluated the contribution of individual constituents through luciferase reporter assays. Throughout this optimization, essential core components such as creatine phosphate (CrP), creatine kinase (CrK), ATP, GTP, magnesium, and potassium were maintained in the base reaction mixture3,8,19. Our systematic approach allowed us to precisely determine the impact of each component on overall protein synthesis yield, leading to the identification of both dispensable and critical factors.
Through this systematic screening, we first identified several components that could be entirely removed from the reaction mixture without compromising protein synthesis efficiency (Figure 1). Dithiothreitol (DTT), a reducing agent commonly included in both transcription and translation systems to maintain protein sulfhydryl groups in a reduced state and prevent aggregation, was found to be unnecessary within our specific system, as its removal did not affect the final protein expression levels (Figure 1A). Similarly, cyclic adenosine 3′,5′-monophosphate (cAMP), a regulator implicated in transcriptional regulation22–24, was also found to be dispensable for efficient protein synthesis (Figure 1B). Furthermore, we systematically evaluated other auxiliary components, including the molecular crowder polyethylene glycol 8000 (PEG8000), used to enhance macromolecular crowding25–29; ammonium ions (NH4 +), typically included as an osmolyte and for its role in maintaining protein stability and solubility in eCFPS reactions29–33; and folinic acid, which serves as a crucial cofactor for nucleotide synthesis8,33. Our results consistently showed that removing these components had a negligible impact on overall protein synthesis performance (Figure 1C-E). These findings collectively demonstrate that a substantial portion of the auxiliary components in traditional eCFPS protocols can be eliminated, paving the way for a more streamlined and cost-effective system.

Optimization of eCFPS components.
Protein expression levels from the eCFPS system were measured using an Nanoluciferase (NLuc) reporter DNA. Green area in the graphs indicate the common concentration range used in published protocols for eCFPS. Error bars represent the standard error (SE) of at least three independent reactions. (A-E) Protein expression levels of the eCFPS system supplemented with different concentrations of DTT (A), cAMP (B), PEG8000 (C), NH4+ (D), and folinic acid (E). (F-I) Protein expression levels of eCFPS with various concentrations of tRNA (F), amino acids (G), CTP (H) and UTP (I). (J) A summary of the supplement components before and after optimization.
An evaluation of various concentrations of amino acids and tRNA was conducted, as these components are fundamental building blocks for protein synthesis34–36. Previous studies on eCFPS have highlighted the rapid degradation of certain amino acids, such as arginine, cysteine, and tryptophan, necessitating their replenishment for prolonged synthesis37,38. Our results showed that while these components are critical for achieving high yields, protein synthesis still occurs in their absence (Figure 1F-G). This suggests that while they are optimizable, tRNA and amino acids are not strictly essential for the reaction to proceed, likely due to residual amounts within the cell lysate (Figure 1F-G). Furthermore, we evaluated the role of nucleoside triphosphates (NTPs) in our system, which are essential for coupled transcription-translation. Interestingly, we found that protein synthesis could proceed without the addition of CTP or UTP (Figure 1H-I and Figure S1). While adding either ATP or GTP alone resulted in a very weak reaction, the presence of both ATP and GTP together recovered the reaction to approximately 40% of the complete NTPs mix (Figure S1B-C). This highlights the critical role for ATPase-dependent chaperones (e.g., DnaK) and GTPase-dependent elongation factors (e.g., EF-Tu and EF-G)39, which are crucial for proper protein folding during synthesis40.
Ultimately, this comprehensive screening allowed us to successfully reduce the core reaction components from thirty-five to just seven (Figure 1J).
Optimization of essential eCFPS components
While a core set of seven components was found to be sufficient for protein synthesis, we conducted further fine-tuning to maximize the system’s performance. First, we optimized the concentrations of key salts and energy components (Figure 2). Our findings reveal that the final protein expression level is highly dependent on the concentrations of both magnesium (Mg2+) and potassium ions (K+), which are fundamental for the structural integrity and catalytic activity of ribosomes, and various enzymatic reactions critical to eCFPS41,42. Through a detailed matrix-based optimization, we first identified the optimal concentrations of Mg2+ and K+ to achieve maximum protein expression (Figure 2A). Similarly, we conducted a separate screen to optimize the concentrations of Mg2+ and PEG8000 as previous reports have suggested a cooperative relationship between them17 (Figure 2B).

Optimization of essential components for eCFPS system.
(A) Protein expression levels of the eCFPS system measured at varying concentrations of KGlu and MgGlu2. (B) Protein expression levels of the eCFPS system measured at varying concentrations of MgGlu2 and PEG8000. (C) Protein expression levels of the eCFPS system measured at varying concentrations of ATP and GTP. (D) Protein expression levels of the eCFPS system measured at varying concentrations of CrK and CrP. (E) Protein expression levels of the eCFPS system measured at varying pH and buffer concentrations. Data from all panels present mean ± SE, n = 3.
A comprehensive evaluation of the core energy components was also performed. We specifically focused on co-optimizing the concentrations of ATP and GTP, which serve as both energy sources and building blocks43–45, to maximize the yield of protein synthesis (Figure 2C). Additionally, the energy regeneration system, primarily composed of CrP and CrK, is vital for maintaining sustained ATP levels46,47. We found that CrP is crucial, with no reaction occurring in its absence (Figure S2A). Initial experiments showed that while CrK addition significantly boosted translation efficiency early on, reactions without exogenous CrK could achieve a protein expression level approximately four times higher at later time points (2 hours or more), suggesting the presence of an endogenous CrK-like enzyme in the lysate (Figure S2B). A co-optimization screen for CrP and CrK concentrations was also performed, and our results showed that optimizing the concentrations of these components is critical for achieving and sustaining high protein expression (Figure 2D). Furthermore, we optimized the pH and concentration of the HEPES buffer, finding that a specific range was critical for maintaining stable and high protein expression (Figure 2E). These multi-faceted optimizations ensured that each component was present at its ideal concentration, leading to a synergistic effect that significantly boosted the system’s overall performance.
Performance characterization of the optimized eCFPS
To thoroughly evaluate the performance of our optimized eCFPS, we conducted a series of experiments. We first investigated the kinetics of protein synthesis measuring the expression over time at different temperatures (25°C, 30°C, and 37°C). Our results demonstrate that the system exhibits robust protein synthesis across this range, with the highest expression rates observed at the physiological temperature of 37°C (Figure 3A). Next, we assessed the system’s sensitivity to DNA concentration, finding that it could efficiently utilize a wide range of reporter DNA templates to produce quantifiable protein products, which were validated by both luminescence assays and western blot analysis (Figure 3B). Furthermore, we investigated the impact of varying cell lysate volume ratios, comparing our initial system with the newly optimized eCFPS. Our findings indicate that the optimized system maintains superior protein expression even at different lysate-to-buffer ratios (Figure 3C).

Characterization of the optimized eCFPS system.
(A) Kinetics of protein synthesis at 25°C, 30°C and 37°C over a 60-minute period. Data present mean ± SE, n = 3. (B) Protein expression levels of the eCFPS system measured at varying DNA concentrations for a reporter encoding a FLAG-tagged NLuc. The protein product was quantified via a luminescence assay and confirmed by western blotting. Data present mean ± SE, n = 3. (C) Comparison of protein yield. The ‘initial’ system denotes the traditional 35-component reaction mixture prior to optimization, serving as a baseline control for benchmarking the streamlined system. Data present mean ± SE, n = 4.
To distinguish whether the increased protein expression in the optimized system was due to enhanced transcription or translation, we conducted assays using both DNA and pre-transcribed mRNA templates. The results (Figure S4) indicate that while the translation efficiency in the streamlined system showed a slight decrease compared to the initial system, the significant improvement in transcription efficiency resulted in a higher overall protein yield when using DNA templates. This demonstrates that the net performance gain of the optimized eCFPS is primarily driven by enhanced transcription, which more than compensates for the reduction in translational output.
Comparative analysis of energy regeneration systems and expression of challenging proteins
To validate the efficacy of our optimized eCFPS, we benchmarked its performance against two widely used systems: the classical Phosphoenolpyruvate (PEP)-based energy system, a common alternative for ATP regeneration 6,7, and an initial CrP/CrK-based system (Figure 4). We utilized NLuc, representing a broadly applicable protein, and super-folder green fluorescent protein (sfGFP), with codons optimized for E. coli as reporter proteins and monitored their expression over time (Figure 4A-B, Figure S3A). Our results show that the optimized eCFPS consistently outperforms both the classical and initial systems, achieving significantly higher protein expression levels in a shorter period (Figure 4A-B). The robust expression was further confirmed by western blot analysis, which provided clear visual evidence of the superior protein yield from our optimized system (Figure 4C-D, Figure S3B-C). Finally, we validated the function of our system through antibiotic-mediated inhibition assays. Our results demonstrate that protein expression in the optimized eCFPS can be effectively inhibited by standard antibiotics, confirming its robust and native-like translation machinery (Figure S3D).

Benchmarking the optimized eCFPS system with different DNA templates.
(A) NLuc protein expression kinetics over time, comparing the PEP-based, initial CrP/CrK-based, and optimized CrP/CrK-based energy regeneration systems. Data present mean ± SE, n = 4. (B) sfGFP protein expression kinetics over time from the three energy regeneration systems. Data present mean ± SE, n = 3. (C-D) Western blot validation of protein expression for NLuc (C) and sfGFP (D) from the different eCFPS system shown in (A-B). Protein products were detected using an anti-FLAG antibody. The asterisk (*) indicates a non-specific band. (E) Western blot detection of His-FLAG-BsaI expressed by the optimized eCFPS system using an anti-FLAG antibody. (F) Agarose gel electrophoresis confirming the functional activity of eCFPS-synthesized BsaI via cleavage of a substrate plasmid. A 10-fold serial dilution of BsaI was with 1x representing 0.05 mg/mL. NC (negative control) indicates no plasmid in the eCFPS reaction. S, L, and O indicate the respective position of the supercoiled, linear, and open circular forms of the plasmid. (G) Western blot analysis of vimentin expressed by the optimized eCFPS system using an anti-vimentin antibody. (H) Negative-stain electron microscopy image showing that vimentin expressed via eCFPS can successfully self-assemble into filaments in vitro.
To further validate the system’s capability in synthesizing challenging, functional proteins, we focused on the restriction endonuclease BsaI (Figure 4E-F). Restriction endonucleases like BsaI are notoriously difficult to express in vivo due to their specific DNA-cleaving activity, which is highly cytotoxic to the host E. coli cells. Traditional recombinant expression requires the compulsory co-expression of a corresponding methylase to protect the host genome, adding significant complexity to the system48,49. Leveraging the inherent cell-free advantage of circumventing cytotoxicity, we first demonstrated the system’s utility by synthesizing the restriction endonuclease BsaI50, confirming its specific enzymatic activity via a DNA cleavage assay, which underscores the system’s ability to produce complex, functional enzymes (Figure 4E-F). We confirmed that the eCFPS synthesized BsaI was functionally active, successfully cleaving its substrate plasmid DNA (Figure 4F). Based on the standard definition of enzyme activity (1 U digests 1 μg of substrate DNA in 20 μL at 37°C in 1 h), we calculated the enzyme activity of our eCFPS-produced BsaI to be in the range of 2×103 ∼ 2×104 U/mg (Figure 4F). The efficient production of this active enzyme demonstrates the power of our simplified system for producing complex, cytotoxic proteins.
Next, we successfully expressed vimentin, an intermediate filament protein (Figure 4G). Vimentin is a type III intermediate filament protein that forms part of the cytoskeleton51. It is known to be difficult to express and handle due to its high propensity for aggregation. Our eCFPS system efficiently expressed vimentin (Figure 4G). Crucially, the vimentin expressed in our CFPS system demonstrated successful in vitro self-assembly into filaments (Figure 4H), which was confirmed by negative-stain electron microscopy, confirming the system’s robust performance even for difficult-to-express, aggregation-prone proteins (Figure 4E-H).
A simplified method for bacterial lysate preparation and quality control
In addition to optimizing the reaction buffer, we sought to simplify the entire eCFPS procedure by developing an easy-to-use method for preparing the bacterial cell lysate. During lysate making, traditional methods, which often rely on time-consuming runoff and dialysis procedures21,8, were replaced with a high-pressure homogenizer for efficient cell disruption, eliminating the need for additional dialysis. Compared to traditional biochemical methods such as ultrasonication, lysozyme treatment, or freeze-thaw cycles52, this approach is faster and more convenient (Figure 5A). Additionally, endogenous T7 RNA polymerase in the optimized eCFPS lysate obviates exogenous addition, simplifying preparation and reducing costs while maintaining high translation efficiency (Figure 5A). We validated this new “fast lysate” preparation by rigorous quality control. We tested lysates prepared from cells harvested at various optical densities at 600 nm (OD600). While the density did not significantly impact protein expression levels, a harvest optical density of OD600=2 yielded the best performance (Figure 5B). The quality of the lysate, particularly the integrity of its translational machinery, was further confirmed by sucrose gradient centrifugation (Figure S4A) and negative-staining transmission electron microscopy (TEM) images (Figure S4B) showing well-resolved 70S ribosomes.

Preparation of eCFPS from cultured E. coli Cells.
(A) Flowchart of the eCFPS preparation procedures. (B) Comparison of reaction efficiency in eCFPS using lysate with bacteria cells harvested at different optical density. Data present mean ± SE, n = 3. (C) Sucrose gradient sedimentation analysis of different lysates used for eCFPS, revealing the presence of ribosome monomers. (D) Comparison of protein expression levels in eCFPS system using lysates prepared by runoff, dialysis, and rapid endogenous T7 RNA polymerase induction. Data present mean ± SE, n = 4. (E) Comparison of reaction efficiency in eCFPS using lysates after different numbers of freeze-thaw cycles. Data present mean ± SE, n = 3.
To further simplify the protocol, we evaluated the necessity of the traditional runoff and dialysis steps8 (Figure 5A). Our results from sucrose gradient analysis and TEM imaging confirmed that ribosomes remained intact, and the eCFPS expression signal was significantly higher without them (Figure 5C-D, Figure S4B). These findings confirm that both the runoff and dialysis steps are dispensable for our system, allowing for a significantly simplified and faster preparation. Additionally, our reliance on endogenously expressed T7 RNA polymerase yields a significantly higher expression signal, outperforming previously reported eCFPS systems by up to four-fold (Figure 5D).
Our optimized lysate preparation method yielded highly active and stable extracts. It is capable of sustaining protein synthesis for up to 120 minutes (Figure S4C) and maintains protein synthesis efficiency even after multiple freeze-thaw cycles, making it highly suitable for routine laboratory use (Figure 5E).
Discussion
In this study, we successfully developed a highly streamlined and efficient eCFPS system. By systematically eliminating dispensable components from traditional protocols, we reduced the complexity of the reaction mixture from thirty-five to a core set of just seven components. This simplification represents a significant advancement over conventional systems by not only drastically lowering the cost and effort of preparing the reaction buffer, but also by minimizing potential inhibitory interactions between numerous auxiliary components, thereby making the system more accessible for a wider range of researchers and laboratories.
The thorough optimization of the seven core components was a critical step in achieving high protein expression levels. Our detailed screening of key factors like salts, energy components, and buffer conditions revealed that precise concentrations are essential for optimal performance. The synergistic effect of these optimized components was evident, particularly the energy source and regeneration system, which is based on CrK coupled with CrP37. A notable finding from our optimization was the ability of our system to function effectively without certain components traditionally considered essential. For example, the removal of DTT did not negatively impact protein expression, suggesting that our lysate preparation procedure may maintain sufficient reducing conditions or that the high expression levels are sufficiently rapid that protein aggregation is not a major issue. Similarly, the system’s robust performance without exogenous Arg, Cys, Trp, or CTP/UTP highlights a remarkable metabolic self-sufficiency. By omitting traditional runoff and dialysis steps, our ‘fast lysate’ retains active endogenous enzymes capable of synthesizing specific amino acids from residual precursors, such as deriving Cys and Trp from Ser, and generating Asn and Gln from Asp and Glu53. Furthermore, endogenous nucleotide metabolic enzymes, powered by the CrP/CrK regeneration system, effectively convert residual pools into functional CTP and UTP to support coupled transcription and translation. We also observed that the protein synthesis signal was significantly higher without traditional runoff and dialysis steps, strongly suggesting that these steps may inadvertently remove endogenous components essential for efficient protein synthesis. The high activity of this “fast lysate,” which retains essential endogenous components, is the key factor enabling the dramatic simplification of the reaction buffer. This led to a significant improvement in protein synthesis yield compared to both classical and initial systems.
The benchmarking experiments clearly demonstrated that our optimized eCFPS system provides higher protein expression levels compared to these traditional systems while offering faster kinetics, which is a key advantage for high-throughput applications. The successful production of active BsaI restriction enzyme, a cytosolic toxic and difficult-to-express protein, and the functional assembly of vimentin, a difficult-to-handle intermediate filament protein51, further validate the superior robustness and translational quality of our optimized system beyond simple reporters like Nluc. Comparative assays using DNA and mRNA templates (Figure S3) revealed that the performance gain of the optimized eCFPS is primarily driven by significantly enhanced transcription, which effectively compensates for a modest decrease in translational efficiency compared to the initial system. This trade-off results in a higher net protein yield in standard DNA-driven reactions.
Our simplified lysate preparation method, the novel “fast lysate” protocol which eliminates the time-consuming runoff and dialysis steps, further distinguishes this work. We demonstrate that a highly active lysate can be prepared rapidly using a high-pressure homogenizer, which enhances the overall accessibility and robustness of our eCFPS system. The ability to use the lysate directly after a single centrifugation step, coupled with the reliance on endogenous T7 RNA polymerase, makes our protocol one of the most straightforward and rapid for producing high-quality eCFPS lysates. This streamlined preparation procedure is a significant step toward making CFPS a more routine and scalable tool for diverse applications.
Despite the high efficiency and robustness of our optimized eCFPS system, certain limitations must be acknowledged. First, as a prokaryotic system derived from E. coli, it lacks the complex eukaryotic chaperone systems (e.g., Hsp70/Hsp90 families) and post-translational modification (PTM) machinery required for many human proteins10. Consequently, proteins requiring specific glycosylation, phosphorylation, or complex disulfide bond patterns may exhibit incomplete folding or reduced biological activity10. While we demonstrated that DTT is dispensable for the functional expression of vimentin and Bsal, specialized cysteine-rich proteins may still require exogenous reducing agents to prevent aggregation. Furthermore, while the ‘fast lysate’ protocol significantly lowers the barrier to entry, the expression of certain membrane proteins will likely still require the systematic screening of detergents or synthetic lipids to ensure proper integration and stability.
In conclusion, our optimized and streamlined eCFPS system represents a significant advancement in the field of prokaryotic cell-free protein synthesis. By drastically reducing the number of reaction components and simplifying the lysate preparation procedure, we have created a highly efficient, cost-effective, and user-friendly platform. This system is poised to accelerate fundamental research and facilitate high-throughput protein engineering, compound screening, and diagnostic development. Future work will focus on further characterizing the endogenous factors in the lysate that enable the high efficiency of our system and exploring its use in novel synthetic biology applications.
Methods
Plasmid construction
All plasmids and primers used in this study are detailed in Table S2. The NLuc and sfGFP reporter genes, each fused with a FLAG-tag, were cloned into a T7-driven expression vector. The sfGFP gene was optimized for E. coli codon usage to ensure efficient translation. The vector backbone was constructed using standard molecular biology techniques.
The BsaI linear DNA templates was constructed from three DNA fragments amplified by PCR. To enhance template stability and mitigate nuclease degradation within the CFPS system, approximately 300 bp sequences were incorporated upstream and downstream of the BsaI coding sequence. The fragments encoding the T7 promoter/upstream sequence (Fragment 1) and the T7 terminator/downstream sequence (Fragment 2) were amplified from the pJL1 plasmid. Separately, the gene fragment for the restriction endonuclease BsaI was amplified from the pUC_BsaI plasmid (Fragment 3). These three fragments were subsequently fused using overlap PCR to generate the final linear template, which was confirmed to lack the recognition sequence for the target BsaI enzyme.
E. coli cell culture and lysate preparation
E. coli S30 cell lysate for CFPS was prepared using a simplified protocol adapted from a previously reported method8. Briefly, E. coli BL21(DE3) was cultured in LB medium at 37°C with shaking. Once the OD600 reached 0.8, endogenous T7 RNA polymerase expression was induced with 1 mM IPTG. The culture was then grown for an additional 2 hours before being harvested (when the OD600 reached 2-3). The cells were collected by centrifugation at 4000 g for 10 minutes at 4°C. The cell pellet was washed with 5 volumes of cold S30 buffer (10 mM HEPES-KOH pH 7.5, 14 mM Mg(OAc)2, 60 mM KOAc) and then resuspended in S30 buffer at a ratio of 1 mL per gram of wet cell paste. Cell lysis was performed using a high-pressure homogenizer at 800 bar for two passes. The lysate was then clarified by centrifugation at 20,000 g for 10 minutes at 4°C, and the resulting supernatant, designated as the “fast lysate”, was collected without subsequent runoff or dialysis steps. This omission ensures maximal retention of endogenous components, contributing directly to the observed system efficiency. Lysate quality control was assessed by (i) sucrose density gradient analysis and negative-staining TEM to confirm the integrity of 70S ribosomes, and (ii) functional testing by monitoring the synthesis and activity of the challenging restriction enzyme, BsaI and vimentin. Finally, the fast lysate was aliquoted and flash-frozen in liquid nitrogen before being stored at -80°C until use.
A step-by-step protocol is provided in the supplementary protocol.
eCFPS reactions for luciferase reporter assay
The optimized eCFPS reaction was performed in a 10 μL total volume containing the components listed in Table S3 and Table S4. Plasmid of NLuc reporter gene was used as the template.
CFPS expression, protein purification and analysis
Protein expression levels were quantified using NLuc and sfGFP reporter systems. NLuc activity was measured with the Nano-Glo luciferase assay system (Promega). Reaction mixtures were diluted as specified in the source data to prevent signal saturation and then analyzed on a microplate luminometer (BERTHOLD, Centro XS3 LB 960) to obtain the luminescence units as described previously54,55. Relative Luciferase Units (RLU) were determined by normalizing the raw luminescence intensity of each experimental group to that of a designated control group (typically the ‘initial’ 35-component system). This normalization was performed by dividing the absolute signal of the sample by the mean signal of the control, allowing for consistency across different experimental batches and measurement sessions. SfGFP fluorescence was used to quantify protein synthesis following the methods reported56. Briefly, 5 µL of the reaction mixture was added to 195 µL of fluorescence assay buffer (20mM HEPES-KOH pH7.5, 100mM NaCl, 5mM magnesium glutamate). Fluorescence was measured on a Cell Imaging Multimode Reader (BioTek, Cytation 5) with an excitation wavelength of 485 nm and an emission wavelength of 528 nm.
Western blotting analysis was performed to confirm protein synthesis of the eCFPS reactions. Synthesized proteins were detected using a primary anti-FLAG (Sigma, Cat#: M185-3L). Chemiluminescence was detected using a Gel Imaging System (Tanon).
Preparation of a sfGFP standard curve
To establish a standard curve for the absolute quantification of sfGFP yield, E. coli BL21(DE3) transformed with the pJL1-sfGFP plasmid was inoculated into 5 mL of LB medium containing kanamycin and cultured overnight. Cells were harvested by centrifugation (10,000 g, 5 min), resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 300 mM NaCl), and disrupted using a high-pressure homogenizer at 800 bar for two passes. The clarified supernatant (10,000 g, 20 min) was purified via His-tag affinity chromatography, using 30 mM and 300 mM imidazole for washing and elution, respectively, with purity confirmed by SDS-PAGE.
The purified sfGFP was quantified via an Enhanced BCA Protein Assay Kit (Beyotime) and serially diluted in 50 mM HEPES buffer (pH 7.5) to concentrations ranging from 0.042 to 0.68 mg/mL. Fluorescence was measured using a Cytation 5 Multi-Mode Microplate Reader (BioTek) at an excitation of 485 nm and emission of 528 nm in flat-bottom 96-well half-area black plates. Each dilution was tested in triplicate to generate a standard curve for converting fluorescence intensity into absolute protein concentration (mg/mL).
Expression and purification of vimentin and BsaI
The gene for human vimentin (GenBank NP_003371.2) was sub-cloned into the pET507a vector for expression. BsaI (4 mL reaction) and vimentin (1 mL reaction) proteins were synthesized using a CFPS system. The core reaction mixture for both proteins consisted of 16 mM magnesium glutamate, 250 mM potassium glutamate, 1.2 mM ATP, 2.4 mM GTP, 80 mM CrP, 125 μg/ml CrK, 13.3 ng/μl or 7.2 ng/μl DNA template, and 50% cell extract.
For BsaI purification, the 4 mL reaction mixture was centrifuged at 20,000 g, and the supernatant was incubated with 600 μl of Ni beads for 1 h at 4°C. The beads were washed five times with 2 mL of wash buffer (40 mM HEPES-KOH pH 7.5, 50 mM imidazole, 500 mM NaCl). Elution was performed with 2 mL of elution buffer (40 mM HEPES-KOH pH 7.5, 500 mM imidazole, 500 mM NaCl). The eluted BsaI was desalted using a column (desalting buffer: 40 mM HEPES-KOH pH 7.5, 500 mM NaCl, 1 mM DTT), concentrated to 1 mg/ml, and stored at -80°C in the presence of 10% glycerol. BsaI enzymatic activity was validated in a 20 μL reaction containing 2 μL of 10x rCutsmart (NEB), 2 μg of a substrate plasmid, and BsaI enzyme diluted in a 10-fold gradient. The reaction was incubated at 37°C for 1 h and visualized via agarose gel electrophoresis.
Vimentin synthesis was carried out in a 5 mL nuclease-free tube with static incubation at 37°C for 13 h. The BsaI synthesis was performed in a 10 mL nuclease-free tube at 30°C with shaking at 150 rpm for 13 h.
Vimentin filament assembly
Vimentin, expressed via CFPS, was refolded and prepared for assembly through a multi-step gradient dialysis protocol. The protein was dialyzed at room temperature in a buffer (5 mM Tris−HCl pH 8.5, 1 mM EDTA, 0.1 mM EGTA, 5 mM β-ME) sequentially containing 6 M, 4 M, and 2 M urea, with each step lasting 30 min. Subsequent overnight dialysis was performed at 4°C in the same buffer lacking urea. The protein was finally dialyzed for 1 h at room temperature into 5 mM Tris pH 8.5, 5 mM β-ME, ensuring the protein was in its tetramer configuration, after which the sample was concentrated. To initiate filament assembly, 20 μl of the concentrated protein solution was quickly mixed with 20 μl of assembly buffer (5 mM Tris pH 8.5, 170 mM NaCl, 100 mM KCl, 5 mM MgCl2) in a 200 μl PCR tube. The assembly reaction was incubated for 1 h in a PCR thermocycler preheated to 25°C before being immediately transferred to ice. Filament formation was subsequently verified by negative-stain transmission electron microscopy.
Negative-staining transmission electron microscopy (TEM)
Samples from vimentin assembly, the TEM samples were prepared by negative staining. A glow-discharged, carbon-coated copper grid was first rinsed with 3 μL of protein buffer (5 mM Tris pH 8.5, 5 mM β−ME). Then, 3 μL of the assembled sample solution was incubated on the grid for 20s. The sample was fixed using 3 μL of 0.8% glutaraldehyde solution for 20s. Finally, the grid was stained twice with 3 μl of uranyl acetate solution, with each staining step lasting 90 s. Samples were observed using a Talos F200C transmission electron microscope at a nominal magnification of 92,000.
Samples from the SDG were prepared for TEM. Fresh, glow-discharged carbon-coated grids were immersed in 3 μL of the corresponding sample for 2 minutes. Excess solvent was removed, and the grids were stained with uranyl acetate for 1 minute and air dried.
Sucrose density gradient (SDG) analysis
A volume of 170–180 μL of lysate was loaded onto a 10%–40% (w/w) SDG. The gradient buffer contained 10 mM HEPES-KOH (pH 7.5), 14 mM Mg(OAc)2, 60 mM KOAc. The gradient was prepared using a simple diffusion method (Biocomp) and centrifugation at 38,000 rpm for 2.5 hours at 4°C in a Beckman SW41Ti rotor. Following centrifugation, the gradient was fractionated using a density gradient fractionation system (Biocomp), with continuous monitoring of the absorbance at 260 nm.
Data availability
All data generated or analyzed during this study are included in the manuscript and the supplementary information. Specifically, source data files have been provided for all figures, and the optimized reaction components and concentrations are detailed in the main text and Supplementary Tables. All plasmids and linear DNA templates used are described in the Methods section.
Acknowledgements
We thank Alexey Amunts for helpful discussions. We also thank Jian Li and Wanqiu Liu from Shanghai Tech University for providing the endonuclease plasmids and sharing the linear fragment construction method. This work was supported by grants from the National Key Research and Development Program of China (2022YFA0807100), National Natural Science Foundation of China (32171291 and 32371351), Nature Science Foundation of Shandong Province (ZR2021QC002) the Shandong Excellent Young Scientists Fund Program (2022HWYQ-025), Taishan Scholars Program (tsqnz20221104), Cutting Edge Development Fund of Advanced Medical Research Institute (GYY2023QY01) and the Cheeloo Youth Program of Shandong University to W.L..
Additional information
Contributions
X.L.,C.Z. and J.L. were responsible for obtaining experimental data and performing data processing. X.L. and C.Z. conducted biochemical experiments. X.L., C.Z., Z.Z. and W.L. analyzed the data and created charts. W.L. wrote the initial draft of the paper. All authors edited the paper.
Funding
MOST | National Key Research and Development Program of China (NKPs) (2022YFA0807100)
Wenfei Li
MOST | National Natural Science Foundation of China (NSFC) (32171291)
Wenfei Li
MOST | National Natural Science Foundation of China (NSFC) (32371351)
Wenfei Li
Additional files
References
- 1.Cell-free protein synthesis: applications come of ageBiotechnol. Adv 30:1185–1194https://doi.org/10.1016/j.biotechadv.2011.09.016PubMedGoogle Scholar
- 2.The past, present and future of cell-free protein synthesisTrends Biotechnol 23:150–156https://doi.org/10.1016/j.tibtech.2005.01.003PubMedGoogle Scholar
- 3.Cell-free protein synthesis from genomically recoded bacteria enables multisite incorporation of noncanonical amino acidsNat. Commun 9:1203https://doi.org/10.1038/s41467-018-03469-5PubMedGoogle Scholar
- 4.Adding new chemistries to the genetic codeAnnu. Rev. Biochem 79:413–444https://doi.org/10.1146/annurev.biochem.052308.105824PubMedGoogle Scholar
- 5.Designing logical codon reassignment - Expanding the chemistry in biologyChem. Sci 6:50–69https://doi.org/10.1039/c4sc01534gPubMedGoogle Scholar
- 6.Constructing cell-free expression systems for low-cost accessACS Synth. Biol 11:1114–1128https://doi.org/10.1021/acssynbio.1c00342PubMedGoogle Scholar
- 7.A user’s guide to cell-free protein synthesisMethods Protoc 2:24https://doi.org/10.3390/mps2010024PubMedGoogle Scholar
- 8.Development of a robust Escherichia coli-based cell-free protein synthesis application platformBiochem. Eng. J 165:107830https://doi.org/10.1016/j.bej.2020.107830PubMedGoogle Scholar
- 9.Translation related factors improve the productivity of a Streptomyces-based cell-free protein synthesis systemACS Synth. Biol 9:1221–1224https://doi.org/10.1021/acssynbio.0c00140PubMedGoogle Scholar
- 10.Cell-free protein synthesis: Pros and cons of prokaryotic and eukaryotic systemsChembiochem 16:2420–2431https://doi.org/10.1002/cbic.201500340PubMedGoogle Scholar
- 11.Cell-free protein synthesis enabled rapid prototyping for metabolic engineering and synthetic biologySynth. Syst. Biotechnol 3:90–96https://doi.org/10.1016/j.synbio.2018.02.003PubMedGoogle Scholar
- 12.Cell-free protein synthesis at high temperatures using the lysate of a hyperthermophileJ. Biotechnol 126:186–195https://doi.org/10.1016/j.jbiotec.2006.04.010PubMedGoogle Scholar
- 13.Establishing a high-yield Bacillus subtilis-based cell-free protein synthesis system for in vitro prototyping and natural product biosynthesisACS Synth. Biol 14:1288–1297https://doi.org/10.1021/acssynbio.5c00021PubMedGoogle Scholar
- 14.Recent advances in cell-free unnatural protein synthesisSheng Wu Gong Cheng Xue Bao 34:1371–1385https://doi.org/10.13345/j.cjb.180203PubMedGoogle Scholar
- 15.Recent advances in development of cell-free protein synthesis systems for fast and efficient production of recombinant proteinsFEMS Microbiol. Lett 365https://doi.org/10.1093/femsle/fny174PubMedGoogle Scholar
- 16.Cell-free expression of a therapeutic protein serratiopeptidaseMolecules 28:3132https://doi.org/10.3390/molecules28073132PubMedGoogle Scholar
- 17.Cell-free production and stable-isotope labeling of milligram quantities of proteinsFEBS Lett 442:15–19https://doi.org/10.1016/s0014-5793(98)01620-2PubMedGoogle Scholar
- 18.Tuning the cell-free protein synthesis system for biomanufacturing of monomeric human filaggrinFront. Bioeng. Biotechnol 8:590341https://doi.org/10.3389/fbioe.2020.590341PubMedGoogle Scholar
- 19.A highly optimized human in vitro translation systemCell Rep. Methods 4:100755https://doi.org/10.1016/j.crmeth.2024.100755PubMedGoogle Scholar
- 20.A highly efficient human cell-free translation systemRNA 29:1960–1972https://doi.org/10.1261/rna.079825.123PubMedGoogle Scholar
- 21.Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technologyJ. Vis. Exp https://doi.org/10.3791/58882-vGoogle Scholar
- 22.Regulating gene transcription in response to cyclic AMP elevationCell. Signal 20:460–466https://doi.org/10.1016/j.cellsig.2007.10.005PubMedGoogle Scholar
- 23.Cyclic AMP signaling and gene regulationAnnu. Rev. Nutr 18:353–383https://doi.org/10.1146/annurev.nutr.18.1.353PubMedGoogle Scholar
- 24.A cyclic AMP response element mediates repression of tyrosine aminotransferase gene transcription by the tissue-specific extinguisher locus Tse-1Cell 61:905–916https://doi.org/10.1016/0092-8674(90)90201-oPubMedGoogle Scholar
- 25.Macromolecular crowding by polyethylene glycol reduces protein breathingJ. Phys. Chem. Lett 14:2599–2605https://doi.org/10.1021/acs.jpclett.3c00271PubMedGoogle Scholar
- 26.Cell-free protein expression under macromolecular crowding conditionsPLoS One 6:e28707https://doi.org/10.1371/journal.pone.0028707PubMedGoogle Scholar
- 27.Polyethylene glycol impacts conformation and dynamics of Escherichia coli prolyl-tRNA synthetase via crowding and confinement effectsBiochemistry 63:1621–1635https://doi.org/10.1021/acs.biochem.3c00719PubMedGoogle Scholar
- 28.Optimal molecular crowding accelerates group II intron folding and maximizes catalysisProc. Natl. Acad. Sci. U. S. A 115:11917–11922https://doi.org/10.1073/pnas.1806685115PubMedGoogle Scholar
- 29.Development and comparison of cell-free protein synthesis systems derived from typical bacterial chassisBioresour. Bioprocess 8:58https://doi.org/10.1186/s40643-021-00413-2PubMedGoogle Scholar
- 30.Osmolyte effects on protein stability and solubility: a balancing act between backbone and side-chainsBiophys. Chem 159:90–99https://doi.org/10.1016/j.bpc.2011.05.012PubMedGoogle Scholar
- 31.Osmolyte-induced folding and stability of proteins: Concepts and characterizationIran. J. Pharm. Res 18:13–30https://doi.org/10.22037/ijpr.2020.112621.13857PubMedGoogle Scholar
- 32.Cell-free gene expression: Methods and applicationsChem. Rev 125:91–149https://doi.org/10.1021/acs.chemrev.4c00116PubMedGoogle Scholar
- 33.A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell-free protein synthesis systemsBiotechnol. Prog 31:823–831https://doi.org/10.1002/btpr.2082PubMedGoogle Scholar
- 34.The effect of tRNA concentration on the rate of protein synthesisProc. Natl. Acad. Sci. U. S. A 62:566–573https://doi.org/10.1073/pnas.62.2.566PubMedGoogle Scholar
- 35.Processing of tRNA in prokaryotes and eukaryotesCRC Crit. Rev. Biochem 17:45–71https://doi.org/10.3109/10409238409110269PubMedGoogle Scholar
- 36.Translation in prokaryotesCold Spring Harb. Perspect. Biol 10https://doi.org/10.1101/cshperspect.a032664PubMedGoogle Scholar
- 37.Prolonging cell-free protein synthesis by selective reagent additionsBiotechnol. Prog 16:385–390https://doi.org/10.1021/bp000031yPubMedGoogle Scholar
- 38.Prolonging cell-free protein synthesis with a novel ATP regeneration systemBiotechnol. Bioeng 66:180–188https://doi.org/10.1002/(sici)1097-0290(1999)66:3<180::aid-bit6>3.0.co;2-sPubMedGoogle Scholar
- 39.Elongation in translation as a dynamic interaction among the ribosome, tRNA, and elongation factors EF-G and EF-TuQ. Rev. Biophys 42:159–200https://doi.org/10.1017/s0033583509990060PubMedGoogle Scholar
- 40.The Hsp70-chaperone machines in bacteriaFront. Mol. Biosci 8:694012https://doi.org/10.3389/fmolb.2021.694012PubMedGoogle Scholar
- 41.Mg2+, K+, and the ribosomeJournal of bacteriology 196:3817–3819https://doi.org/10.1128/jb.02297-14PubMedGoogle Scholar
- 42.Unfolding of Escherichia coli ribosomes by removal of magnesiumJ. Mol. Biol 18:356–371https://doi.org/10.1016/s0022-2836(66)80253-xPubMedGoogle Scholar
- 43.Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applicationsRSC Chem. Biol 1:333–351https://doi.org/10.1039/d0cb00078gPubMedGoogle Scholar
- 44.An economical method for cell-free protein synthesis using glucose and nucleoside monophosphatesBiotechnol. Prog 21:1146–1153https://doi.org/10.1021/bp050052yPubMedGoogle Scholar
- 45.A novel cell-free protein synthesis systemJ. Biotechnol 110:257–263https://doi.org/10.1016/j.jbiotec.2004.02.014PubMedGoogle Scholar
- 46.Creatine phosphate administration in cell energy impairment conditions: A summary of past and present researchHeart Lung Circ 26:1026–1035https://doi.org/10.1016/j.hlc.2016.12.020PubMedGoogle Scholar
- 47.The creatine kinase system and pleiotropic effects of creatineAmino Acids 40:1271–1296https://doi.org/10.1007/s00726-011-0877-3PubMedGoogle Scholar
- 48.Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbentNat. Biotechnol 6:1321–1325https://doi.org/10.1038/nbt1188-1321Google Scholar
- 49.Structures of restriction endonuclease HindIII in complex with its cognate DNA and divalent cationsActa Crystallogr. D Biol. Crystallogr 65:1326–1333https://doi.org/10.1107/s0907444909041134PubMedGoogle Scholar
- 50.Specific cleavage of simian virus 40 DNA by restriction endonuclease of Hemophilus influenzaeProc. Natl. Acad. Sci. U. S. A 68:2913–2917https://doi.org/10.1073/pnas.68.12.2913PubMedGoogle Scholar
- 51.Vimentin filaments integrate low-complexity domains in a complex helical structureNat. Struct. Mol. Biol 31:939–949https://doi.org/10.1038/s41594-024-01261-2PubMedGoogle Scholar
- 52.Biochemical preparation of cell extract for cell-free protein synthesis without physical disruptionPLoS One 11:e0154614https://doi.org/10.1371/journal.pone.0154614PubMedGoogle Scholar
- 53.An economical method for producing stable-isotope labeled proteins by the E. coli cell-free systemJ. Biomol. NMR 48:193–201https://doi.org/10.1007/s10858-010-9455-3PubMedGoogle Scholar
- 54.Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like moleculeNat. Struct. Mol. Biol 26:501–509https://doi.org/10.1038/s41594-019-0236-8PubMedGoogle Scholar
- 55.Human ribosome interactions reframe neomycin toxicityBioRxiv https://doi.org/10.1101/2025.07.22.666027Google Scholar
- 56.IRES-mediated Pichia pastoris cell-free protein synthesisBioresour. Bioprocess 10:35https://doi.org/10.1186/s40643-023-00653-4PubMedGoogle Scholar
Article and author information
Author information
Version history
- Sent for peer review:
- Preprint posted:
- Reviewed Preprint version 1:
- Reviewed Preprint version 2:
Cite all versions
You can cite all versions using the DOI https://doi.org/10.7554/eLife.109495. This DOI represents all versions, and will always resolve to the latest one.
Copyright
© 2025, Lang et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
- views
- 1,927
- downloads
- 314
- citations
- 0
Views, downloads and citations are aggregated across all versions of this paper published by eLife.